AstraZeneca Pharma India informs about disclosure

04 Dec 2024 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, AstraZeneca Pharma India has informed that the Company has received an order from the Income-tax Appellate Tribunal (‘ITAT’) issued under section 254 of the Income Tax Act, 1961 for the assessment year 2017-18 and 2018-19 on December 3, 2024. In this regard, the company has enclosed the details as required under the SEBI Circular SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated July 13, 2023 attached as Annexure – A.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

6480.70 -51.55 (-0.79%)
18-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.30
Dr. Reddys Lab 1275.05
Cipla 1472.05
Lupin 2098.70
Zydus Lifesciences 979.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.